During the 2024 Peripheral Nerve Society meeting (pnsociety.com), held in Montreal (Canada), one of ENU members, Paola Alberti, MD, PhD was assigned the role as chair of the junior committee for a 2-years term. She is also serving as an ex-officio board member
ENU@MASCC
One of ENU members, Paola Alberti, MD, PhD, is taking part in the Multinational Association for Supportive Care in Cancer (MASCC) annual meeting in Lille, France, from 27th to 29th June 2024, in her role of chair of the MASCC
ENU @PNS2024
The 2024 annual PNS (Peripheral Nerve Society) meeting will take place in Montreal (Canada) from June 22 to June 25, 2024. A number of ENU researchers will join the meeting and present their latest findings: Posters Malacrida A*, Molteni L,
Cristina Meregalli awarded the AINP ONLUS 2024 Award
During the Fourteenth Annual Meeting of the Italian Association for the Study of the Peripheral Nervous System, held in Trieste from 30 May to 1 June 2024, Cristina Meregalli was awarded the prestigious AINP (Italian Association of Peripheral Neuropathies) ONLUS
ENU@ASNP2024 in Trieste
The 14th meeting of the ASNP (Italian association for the study of the peripheral nervous system) will take place in Trieste (Italy) from May 30 to June 1, 2024. A number of ENU researchers will join the meeting and present
Lecture on preclinical translational methods in CIPN under an initiative of NIH
The National Institute of Health is organising a series of webinar titled Building bridges in Cancer Symptoms Science. On 18th June a webinar dedicated to Chemotherapy-Induced Peripheral Neurotoxicity is scheduled: Methods and Techniques for Clinical and Preclinical Chemotherapy-induced Peripheral Neuropathy
Collaboration with the United Nations at the WHO General Assembly
On May 29, 2024, during the 77th World Health Assembly (WHO), Professor Guido Cavaletti, in the role of Univerity of Milano-Bicocca’s Pro-Rector for Research, will participate in the Breakfast Roundtable – a Side Event at the WHO, organized by the United Nations Institute for
Translation of paclitaxel-induced peripheral neurotoxicity from mice to patients: the importance of model selection
Cavaletti G, Alberti P, Canta A, Carozzi V, Cherchi L, Chiorazzi A, Crippa L, Marmiroli P, Meregalli C, Pozzi E, Rodriguez-Menendez V, Steinkühler C, Licandro SA. Translation of paclitaxel-induced peripheral neurotoxicity from mice to patients: the importance of model selection.
Current use of fluid biomarkers as outcome measures in Multiple Sclerosis (MS): a review of ongoing pharmacological clinical trials
Schilke ED, Remoli G, Funelli E, Galimberti M, Fusco ML, Cereda D, Balducci C, Frigo M, Cavaletti G. Current use of fluid biomarkers as outcome measures in Multiple Sclerosis (MS): a review of ongoing pharmacological clinical trials. Neurol Sci. 2024
Natural compounds as anticancer therapies
Cancer currently represents one of the main causes of death worldwide. Conventional treatments include surgery, chemotherapy, and radiotherapy. In order to increase patient survival and improve their quality of life, it is very important to identify alternatives to classic anti-tumor